<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Professional Medical Billing&#187; Stem Cell</title>
	<atom:link href="http://www.promedbilling.com/tag/stem-cell/feed" rel="self" type="application/rss+xml" />
	<link>http://www.promedbilling.com</link>
	<description>Medical billing firm providing medical billing services and medical billing consulting throughout the state of Michigan.</description>
	<lastBuildDate>Tue, 07 Sep 2010 08:20:15 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Important Breakthrough In Origins Of Aggressive Breast Cancer</title>
		<link>http://www.promedbilling.com/2010/09/03/important-breakthrough-in-origins-of-aggressive-breast-cancer/</link>
		<comments>http://www.promedbilling.com/2010/09/03/important-breakthrough-in-origins-of-aggressive-breast-cancer/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 15:00:00 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Flu]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/09/03/important-breakthrough-in-origins-of-aggressive-breast-cancer/</guid>
		<description><![CDATA[Researchers have made a major breakthrough in finding out how aggressive cancers originate, raising hope of novel targeted therapies for future breast cancer patients, according to a study published in the peer-reviewed journal Cell Stem Cell. The scientists say this is the first study to show that the most aggressive cancers probably arise from intermediary, [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/09/03/important-breakthrough-in-origins-of-aggressive-breast-cancer//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Skin Converted Into Liver Cells &#8211; Potential Cell-based Therapy For Patients With Liver And Other Diseases</title>
		<link>http://www.promedbilling.com/2010/08/25/skin-converted-into-liver-cells-potential-cell-based-therapy-for-patients-with-liver-and-other-diseases/</link>
		<comments>http://www.promedbilling.com/2010/08/25/skin-converted-into-liver-cells-potential-cell-based-therapy-for-patients-with-liver-and-other-diseases/#comments</comments>
		<pubDate>Wed, 25 Aug 2010 21:00:00 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Stem Cell]]></category>
		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/08/25/skin-converted-into-liver-cells-potential-cell-based-therapy-for-patients-with-liver-and-other-diseases/</guid>
		<description><![CDATA[Researchers have managed to convert skin from individuals with metabolic diseases into liver cells using stem cell technology, according to an article published in the Journal of Clinical Investigation. This research will allow scientists to determine precisely what is happening in a diseased liver cell, then try out potential treatments. The scientists say that eventually [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/08/25/skin-converted-into-liver-cells-potential-cell-based-therapy-for-patients-with-liver-and-other-diseases//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Concern Over Stem Cell Research Federal District Court Injunction By Scientists And Medical Associations</title>
		<link>http://www.promedbilling.com/2010/08/25/concern-over-stem-cell-research-federal-district-court-injunction-by-scientists-and-medical-associations/</link>
		<comments>http://www.promedbilling.com/2010/08/25/concern-over-stem-cell-research-federal-district-court-injunction-by-scientists-and-medical-associations/#comments</comments>
		<pubDate>Wed, 25 Aug 2010 20:00:00 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/08/25/concern-over-stem-cell-research-federal-district-court-injunction-by-scientists-and-medical-associations/</guid>
		<description><![CDATA[The AACR (American Association for Cancer Research) has expressed concern that a recent Federal District Court injunction to stop federal funding for human embryonic stem cell research is a serious obstacle for scientific discovery. The AACR reiterates its support for responsible conduct of human embryonic stem cell research, which up to this week was funded [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/08/25/concern-over-stem-cell-research-federal-district-court-injunction-by-scientists-and-medical-associations//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Kan., Mich., Primaries Touch On Reproductive Issues</title>
		<link>http://www.promedbilling.com/2010/08/05/kan-mich-primaries-touch-on-reproductive-issues/</link>
		<comments>http://www.promedbilling.com/2010/08/05/kan-mich-primaries-touch-on-reproductive-issues/#comments</comments>
		<pubDate>Thu, 05 Aug 2010 12:00:00 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Abortion]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Mich.]]></category>
		<category><![CDATA[Michigan]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/08/05/kan-mich-primaries-touch-on-reproductive-issues/</guid>
		<description><![CDATA[Voters in Kansas and Michigan headed to the polls Tuesday in primaries in which abortion rights and embryonic stem cell research have come into play. ~ Kansas: Sen. Sam Brownback (R) &#8220;easily&#8221; defeated Joan Heffington in the state&#8217;s Republican gubernatorial primary, the AP/Fort Worth Star-Telegram reports. Brownback, who made a brief presidential bid in 2007, [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/08/05/kan-mich-primaries-touch-on-reproductive-issues//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Scientists identify new mechanism that controls number of hematopoietic stem cells</title>
		<link>http://www.promedbilling.com/2010/08/05/scientists-identify-new-mechanism-that-controls-number-of-hematopoietic-stem-cells/</link>
		<comments>http://www.promedbilling.com/2010/08/05/scientists-identify-new-mechanism-that-controls-number-of-hematopoietic-stem-cells/#comments</comments>
		<pubDate>Thu, 05 Aug 2010 07:20:17 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Gene]]></category>
		<category><![CDATA[Hospital]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Stem Cell]]></category>
		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/08/05/scientists-identify-new-mechanism-that-controls-number-of-hematopoietic-stem-cells/</guid>
		<description><![CDATA[Investigators have identified a new mechanism that controls the number of hematopoietic stem cells &#8211; cells that give rise to all blood and immune system cells. In a report in the online Early Edition of Proceedings of the National Academy of Sciences, researchers from Massachusetts General Hospital (MGH) and the Harvard Stem Cell Institute identify [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/08/05/scientists-identify-new-mechanism-that-controls-number-of-hematopoietic-stem-cells//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Approves Embryonic Stem Cell-Based Therapy For Patients With Acute Spinal Cord Injury</title>
		<link>http://www.promedbilling.com/2010/07/31/fda-approves-embryonic-stem-cell-based-therapy-for-patients-with-acute-spinal-cord-injury/</link>
		<comments>http://www.promedbilling.com/2010/07/31/fda-approves-embryonic-stem-cell-based-therapy-for-patients-with-acute-spinal-cord-injury/#comments</comments>
		<pubDate>Sat, 31 Jul 2010 14:00:00 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Food and Drug Administration]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/07/31/fda-approves-embryonic-stem-cell-based-therapy-for-patients-with-acute-spinal-cord-injury/</guid>
		<description><![CDATA[The US FDA (Food and Drug Administration) has lifted a clinical hold on Geron&#8217;s Investigational New Drug (IND) application &#8211; the Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may now go ahead. GRNOPC1 is the first ever clinical trial of a human embryonic stem cell based therapy in humans. [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/07/31/fda-approves-embryonic-stem-cell-based-therapy-for-patients-with-acute-spinal-cord-injury//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Scientists Use Stem Cells to Help Rabbits Grow New Joints</title>
		<link>http://www.promedbilling.com/2010/07/29/scientists-use-stem-cells-to-help-rabbits-grow-new-joints/</link>
		<comments>http://www.promedbilling.com/2010/07/29/scientists-use-stem-cells-to-help-rabbits-grow-new-joints/#comments</comments>
		<pubDate>Thu, 29 Jul 2010 16:40:02 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/07/29/scientists-use-stem-cells-to-help-rabbits-grow-new-joints/</guid>
		<description><![CDATA[Animals were up and hopping again within weeks, but experts say human trials still far off Source: HealthDay Related MedlinePlus Pages: Joint Disorders, Stem Cells Read more]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/07/29/scientists-use-stem-cells-to-help-rabbits-grow-new-joints//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cells That Retain Their Waste Disposal Proteins Appear To Live Longer</title>
		<link>http://www.promedbilling.com/2010/07/26/cells-that-retain-their-waste-disposal-proteins-appear-to-live-longer/</link>
		<comments>http://www.promedbilling.com/2010/07/26/cells-that-retain-their-waste-disposal-proteins-appear-to-live-longer/#comments</comments>
		<pubDate>Mon, 26 Jul 2010 16:00:00 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Stem Cell]]></category>
		<category><![CDATA[Toxic]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/07/26/cells-that-retain-their-waste-disposal-proteins-appear-to-live-longer/</guid>
		<description><![CDATA[US researchers studying yeast cells found that ageing cells able to retain a group of proteins that ferry compounds across cellular membranes and get rid of toxic waste have a longer lifespan in that they can produce more copies of themselves compared with cells that lose their waste disposal proteins; they also hope their finding [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/07/26/cells-that-retain-their-waste-disposal-proteins-appear-to-live-longer//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AXcess News: Adult Stem Cell Research Gets U.S. Army&#8217;s Approval</title>
		<link>http://www.promedbilling.com/2010/07/22/axcess-news-adult-stem-cell-research-gets-u-s-armys-approval/</link>
		<comments>http://www.promedbilling.com/2010/07/22/axcess-news-adult-stem-cell-research-gets-u-s-armys-approval/#comments</comments>
		<pubDate>Thu, 22 Jul 2010 14:00:00 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Stem Cell]]></category>
		<category><![CDATA[U.S.]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/07/22/axcess-news-adult-stem-cell-research-gets-u-s-armys-approval/</guid>
		<description><![CDATA[Adult stem cell leader Neostem, Inc. (NYSE Amex: NBS) has been awarded a $700,000 military grant from the U.S. Army&#8217;s Medical Research and Materiel Command to study adult stem cell applications in the healing of trauma wounds. The award opens new opportunities for the company&#8217;s patented VSEL technology. Shares of Neostem rose more than 5 [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/07/22/axcess-news-adult-stem-cell-research-gets-u-s-armys-approval//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stem cell transplantation from healthy donor helps cure aggressive form of CLL</title>
		<link>http://www.promedbilling.com/2010/07/13/stem-cell-transplantation-from-healthy-donor-helps-cure-aggressive-form-of-cll/</link>
		<comments>http://www.promedbilling.com/2010/07/13/stem-cell-transplantation-from-healthy-donor-helps-cure-aggressive-form-of-cll/#comments</comments>
		<pubDate>Tue, 13 Jul 2010 09:01:01 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Gene]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Hospital]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/07/13/stem-cell-transplantation-from-healthy-donor-helps-cure-aggressive-form-of-cll/</guid>
		<description><![CDATA[The transplantation of stem cells from a healthy donor (allogeneic) offers the chance of cure for patients with an aggressive form of chronic lymphocytic leukemia (CLL), irrespective of genetic prognostic factors and the prior course of the disease. The German CLL Study Group proved this in a multicentric clinical phase II study led by Professor [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/07/13/stem-cell-transplantation-from-healthy-donor-helps-cure-aggressive-form-of-cll//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cutting the Cord</title>
		<link>http://www.promedbilling.com/2010/07/01/cutting-the-cord/</link>
		<comments>http://www.promedbilling.com/2010/07/01/cutting-the-cord/#comments</comments>
		<pubDate>Thu, 01 Jul 2010 13:07:58 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/07/01/cutting-the-cord/</guid>
		<description><![CDATA[Source: HealthDay &#8211; Related MedlinePlus Pages: Childbirth, Stem Cells Read more]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/07/01/cutting-the-cord//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Extracted Teeth Could Be Easy Source Of Stem Cells</title>
		<link>http://www.promedbilling.com/2010/06/28/extracted-teeth-could-be-easy-source-of-stem-cells/</link>
		<comments>http://www.promedbilling.com/2010/06/28/extracted-teeth-could-be-easy-source-of-stem-cells/#comments</comments>
		<pubDate>Mon, 28 Jun 2010 18:00:00 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/06/28/extracted-teeth-could-be-easy-source-of-stem-cells/</guid>
		<description><![CDATA[New research from Japan suggests that dental pulp from extracted teeth may be an easy source of Induced Pluripotent Stem (IPS) cells, which like embryonic stem cells, have the potential to form several different cell types, but without the controversial ethical problems. These were the findings of a study led by K. Tezuka from the [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/06/28/extracted-teeth-could-be-easy-source-of-stem-cells//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cellonis&#8217; stem cells diabetes treatment helps reconstruct natural insulin production</title>
		<link>http://www.promedbilling.com/2010/06/24/cellonis-stem-cells-diabetes-treatment-helps-reconstruct-natural-insulin-production/</link>
		<comments>http://www.promedbilling.com/2010/06/24/cellonis-stem-cells-diabetes-treatment-helps-reconstruct-natural-insulin-production/#comments</comments>
		<pubDate>Thu, 24 Jun 2010 22:00:20 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Stem Cell]]></category>
		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/06/24/cellonis-stem-cells-diabetes-treatment-helps-reconstruct-natural-insulin-production/</guid>
		<description><![CDATA[Cellonis, a Beijing and HK-based biotech company, with its new personalized diabetes treatment concept has demonstrated an amazing improvement in their treated patients&#8217; conditions. The ongoing clinical study shows the treatment&#8217;s best case could reconstruct a patient&#8217;s natural insulin production and even reverse later complications like kidney failure. Treated patients may have the chance to [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/06/24/cellonis-stem-cells-diabetes-treatment-helps-reconstruct-natural-insulin-production//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stem Cell Treatment Restores Vision</title>
		<link>http://www.promedbilling.com/2010/06/24/stem-cell-treatment-restores-vision/</link>
		<comments>http://www.promedbilling.com/2010/06/24/stem-cell-treatment-restores-vision/#comments</comments>
		<pubDate>Thu, 24 Jun 2010 05:00:24 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Web MD]]></category>
		<category><![CDATA[Gene]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Stem Cell]]></category>
		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/06/24/stem-cell-treatment-restores-vision/</guid>
		<description><![CDATA[A regenerative treatment that uses stem cells taken from the patient&#8217;s own eyes is helping some blind patients see again. Read more]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/06/24/stem-cell-treatment-restores-vision//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Combination Effective Against Pancreatic Cancer</title>
		<link>http://www.promedbilling.com/2010/06/16/new-combination-effective-against-pancreatic-cancer/</link>
		<comments>http://www.promedbilling.com/2010/06/16/new-combination-effective-against-pancreatic-cancer/#comments</comments>
		<pubDate>Wed, 16 Jun 2010 09:00:00 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Hospital]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/06/16/new-combination-effective-against-pancreatic-cancer/</guid>
		<description><![CDATA[The new cancer medication sorafenib looks promising. Sorafenib is used for advanced liver and kidney cancer and also appears to be effective against cancer stem cells in pancreatic cancer. The team led by Professor Dr. Ingrid Herr, Head of the Department of Molecular Oncosurgery, a group of the Department of Surgery at Heidelberg University Hospital, [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/06/16/new-combination-effective-against-pancreatic-cancer//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cyntellect launches Stem Cell Colony Purification Application</title>
		<link>http://www.promedbilling.com/2010/06/09/cyntellect-launches-stem-cell-colony-purification-application/</link>
		<comments>http://www.promedbilling.com/2010/06/09/cyntellect-launches-stem-cell-colony-purification-application/#comments</comments>
		<pubDate>Wed, 09 Jun 2010 15:00:04 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/06/09/cyntellect-launches-stem-cell-colony-purification-application/</guid>
		<description><![CDATA[Cyntellect, Inc., a privately-held life sciences company commercializing products to advance the study of cell biology, stem cell research, biopharmaceutical production, and drug discovery, announced today the commercial availability of its Stem Cell Colony Purification Application powered by the LEAP™ Cell Processing Workstation. Read more]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/06/09/cyntellect-launches-stem-cell-colony-purification-application//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tel Aviv University researchers invent new tool to control risk of runaway stem cells</title>
		<link>http://www.promedbilling.com/2010/06/09/tel-aviv-university-researchers-invent-new-tool-to-control-risk-of-runaway-stem-cells/</link>
		<comments>http://www.promedbilling.com/2010/06/09/tel-aviv-university-researchers-invent-new-tool-to-control-risk-of-runaway-stem-cells/#comments</comments>
		<pubDate>Wed, 09 Jun 2010 06:40:31 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/06/09/tel-aviv-university-researchers-invent-new-tool-to-control-risk-of-runaway-stem-cells/</guid>
		<description><![CDATA[Stem cell research holds promise for improving the quality of human life ― especially embryonic stem cells, which can potentially develop into any tissue in the human body. However, basic scientific problems still remain unresolved &#8212; but Tel Aviv University researchers are leading the way to inventive solutions. Read more]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/06/09/tel-aviv-university-researchers-invent-new-tool-to-control-risk-of-runaway-stem-cells//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BioTime offers 5 new human stem cell lines developed using ACTCellerate technology for research use</title>
		<link>http://www.promedbilling.com/2010/05/31/biotime-offers-5-new-human-stem-cell-lines-developed-using-actcellerate-technology-for-research-use/</link>
		<comments>http://www.promedbilling.com/2010/05/31/biotime-offers-5-new-human-stem-cell-lines-developed-using-actcellerate-technology-for-research-use/#comments</comments>
		<pubDate>Mon, 31 May 2010 06:40:01 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/05/31/biotime-offers-5-new-human-stem-cell-lines-developed-using-actcellerate-technology-for-research-use/</guid>
		<description><![CDATA[BioTime, Inc. announced today that on June 1, 2010 the Company will be offering for sale five new human stem cell lines for research use only. These cell lines were developed using BioTime&#8217;s ACTCellerate™ technology. These highly purified, novel, and scalable cell lines are embryonic progenitors, meaning that they are intermediate between human embryonic stem [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/05/31/biotime-offers-5-new-human-stem-cell-lines-developed-using-actcellerate-technology-for-research-use//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stem Cells To Unlock Secrets Of Motor Neurone Disease</title>
		<link>http://www.promedbilling.com/2010/05/24/stem-cells-to-unlock-secrets-of-motor-neurone-disease/</link>
		<comments>http://www.promedbilling.com/2010/05/24/stem-cells-to-unlock-secrets-of-motor-neurone-disease/#comments</comments>
		<pubDate>Mon, 24 May 2010 16:00:00 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Stem Cell]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/05/24/stem-cells-to-unlock-secrets-of-motor-neurone-disease/</guid>
		<description><![CDATA[Being able to grow and program human motor neurones in the lab has been the dream motor neurone disease scientists for several years. The Motor Neurone Disease (MND) Association is funding its first ever stem cell research program with the aim of finding the secrets of this neurological condition. Spelling &#8211; Motor Neurone Disease or [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/05/24/stem-cells-to-unlock-secrets-of-motor-neurone-disease//feed</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Geron Announces Positive Study Data On GRNCM1</title>
		<link>http://www.promedbilling.com/2010/05/15/geron-announces-positive-study-data-on-grncm1/</link>
		<comments>http://www.promedbilling.com/2010/05/15/geron-announces-positive-study-data-on-grncm1/#comments</comments>
		<pubDate>Sat, 15 May 2010 05:00:00 +0000</pubDate>
		<dc:creator>News</dc:creator>
				<category><![CDATA[Medical News]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[Stem Cell]]></category>
		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://www.promedbilling.com/2010/05/15/geron-announces-positive-study-data-on-grncm1/</guid>
		<description><![CDATA[Geron Corporation (Nasdaq:GERN) today reported positive preclinical study data showing that GRNCM1, Geron&#8217;s cardiomyocyte product derived from human embryonic stem cells (hESCs), does not cause cardiac arrhythmias after transplantation into a model of chronic heart damage designed to test this potential safety concern. GRNCM1 is being developed for the treatment of heart failure. The data [...]]]></description>
		<wfw:commentRss>http://www.promedbilling.com/2010/05/15/geron-announces-positive-study-data-on-grncm1//feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
